CICATRICIAL ALOPECIA
Clinical trials for CICATRICIAL ALOPECIA explained in plain language.
Never miss a new study
Get alerted when new CICATRICIAL ALOPECIA trials appear
Sign up with your email to follow new studies for CICATRICIAL ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug aims to halt scarring hair loss
Disease control CompletedThis pilot study tests an experimental drug called ritlecitinib in people with cicatricial alopecia, a type of hair loss where hair follicles are permanently destroyed and replaced by scar tissue. The drug works by blocking certain enzymes involved in inflammation. Researchers wi…
Matched conditions: CICATRICIAL ALOPECIA
Phase: PHASE2 • Sponsor: Emma Guttman • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug shows promise for irreversible hair loss
Disease control CompletedThis study tested a new drug (PF-06700841) in 51 adults with cicatricial alopecia, a type of hair loss that destroys hair follicles and leaves scars. The main goals were to check the drug's safety and see how it affects certain genes in the skin and blood. Researchers hope this w…
Matched conditions: CICATRICIAL ALOPECIA
Phase: PHASE2 • Sponsor: Emma Guttman • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC